Market Summary
USD32.51-0.40
Delayed-1.22%
DOCS Stock Price
DOCS RSI Chart
DOCS Valuation
DOCS Price/Sales (Trailing)
DOCS Profitability
DOCS Fundamentals
DOCS Revenue
DOCS Earnings
Price Action
52 Week Range
22.9154.69
(Low)(High)
Last 7 days
3.2%
Last 30 days
-2.2%
Last 90 days
-4.9%
Trailing 12 Months
-35.1%
DOCS Financial Health
DOCS Investor Care
Financials for Doximity
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | 4.5% | 402 | 384 | 362 | 344 | 317 |
| Gross Profit | 4.5% | 350 | 335 | 317 | 304 | 281 |
| Operating Expenses | 5.6% | 230 | 218 | 206 | 190 | 172 |
| S&GA Expenses | 6.9% | 116 | 109 | 101 | 92.00 | 84.00 |
| R&D Expenses | 6.0% | 76.00 | 72.00 | 68.00 | 62.00 | 57.00 |
| EBITDA | 5.0% | 133 | 127 | 118 | 119 | 113 |
| EBITDA Margin | 0.5% | 0.33* | 0.33* | 0.33* | 0.35* | 0.36* |
| Earnings Before Taxes | 4.3% | 124 | 119 | 112 | 114 | 109 |
| EBT Margin | -0.2% | 0.31* | 0.31* | 0.31* | 0.33* | 0.34* |
| Net Income | -15.7% | 119 | 141 | 151 | 155 | 140 |
| Net Income Margin | -19.4% | 0.30* | 0.37* | 0.42* | 0.45* | 0.44* |
| Free Cahsflow | 14.0% | 177 | 155 | 136 | 125 | 116 |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | 3.8% | 1,067 | 1,028 | 1,051 | 991 | 932 |
| Current Assets | 6.0% | 899 | 848 | 874 | 904 | 858 |
| Cash Equivalents | 85.2% | 136 | 74.00 | 110 | 113 | 85.00 |
| Net PPE | -1.1% | 12.00 | 12.00 | 11.00 | 8.00 | 8.00 |
| Goodwill | 0% | 68.00 | 68.00 | 68.00 | 19.00 | 19.00 |
| Liabilities | -8.3% | 137 | 149 | 149 | 113 | 93.00 |
| Current Liabilities | -10.4% | 106 | 118 | 121 | 111 | 92.00 |
| Shareholder's Equity | 5.8% | 930 | 879 | 902 | 879 | 839 |
| Retained Earnings | 19.7% | 203 | 170 | 205 | 191 | 154 |
| Additional Paid-In Capital | 2.0% | 746 | 731 | 715 | 703 | 688 |
| Accumulated Depreciation | 14.8% | 11.00 | 9.00 | 8.00 | 8.00 | - |
| Shares Outstanding | 0.5% | 193 | 192 | 193 | 192 | 188 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | 13.5% | 180 | 159 | 138 | 127 | 117 |
| Share Based Compensation | 10.2% | 45.00 | 41.00 | 36.00 | 31.00 | 25.00 |
| Cashflow From Investing | 35.6% | -70.34 | -109 | -624 | -640 | -659 |
| Cashflow From Financing | -5.5% | -58.21 | -55.19 | 2.00 | 560 | 558 |
| Buy Backs | 0.1% | 70.00 | 70.00 | 9.00 | 3.00 | 4.00 |
Risks for DOCS
What is the probability of a big loss on DOCS?
84.8%
Probability that Doximity stock will be more than 20% underwater in next one year
82.6%
Probability that Doximity stock will be more than 30% underwater in next one year.
77.2%
Probability that Doximity stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does DOCS drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Doximity was unfortunately bought at previous high price.
Drawdowns
Returns for DOCS
Cumulative Returns on DOCS
Which funds bought or sold DOCS recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -0.04 | 35,454 | 353,454 | -% |
2023-03-10 | BAILLIE GIFFORD & CO | added | 55.99 | 15,899,900 | 37,608,900 | 0.04% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -64.84 | -22,000 | 12,000 | -% |
2023-02-28 | Voya Investment Management LLC | added | 3.13 | 17,723,600 | 139,696,000 | 0.20% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | reduced | -87.27 | -2,530 | 470 | -% |
2023-02-17 | EQUITABLE TRUST CO | reduced | -17.44 | -46,827 | 519,173 | 0.04% |
2023-02-16 | GHP Investment Advisors, Inc. | unchanged | - | 517 | 2,517 | -% |
2023-02-16 | HARBOUR INVESTMENTS, INC. | unchanged | - | -220 | 16,780 | -% |
2023-02-15 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | added | 4.97 | 273,000 | 1,923,000 | 0.01% |
2023-02-15 | MetLife Investment Management, LLC | reduced | -84.02 | -680,974 | 147,026 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Doximity News
Schedule 13G FIlings of Doximity
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Mar 08, 2023 | blackrock inc. | 4.5% | 5,381,384 | SC 13G/A | |
| Feb 14, 2023 | tangney jeffrey | 31.5% | 54,208,180 | SC 13G/A | |
| Feb 14, 2023 | ameriprise financial inc | 2.02% | 2,294,675 | SC 13G/A | |
| Feb 14, 2023 | price t rowe associates inc /md/ | 2.9% | 3,331,877 | SC 13G/A | |
| Feb 14, 2023 | whale rock capital management llc | 0.00% | 0 | SC 13G/A | |
| Feb 13, 2023 | emergence capital partners ii lp | 15.1% | 20,246,728 | SC 13G/A | |
| Feb 10, 2023 | clearbridge investments, llc | 5.1% | 5,805,134 | SC 13G | |
| Feb 09, 2023 | morgan stanley | 13.3% | 15,074,620 | SC 13G/A | |
| Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 8.08% | 9,169,268 | SC 13G/A |
DOCS Fair Value
Recent SEC filings of Doximity
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 08, 2023 | SC 13G/A | Major Ownership Report | |
| Feb 23, 2023 | 4 | Insider Trading | |
| Feb 23, 2023 | 4 | Insider Trading | |
| Feb 16, 2023 | 4 | Insider Trading | |
| Feb 16, 2023 | 4 | Insider Trading | |
| Feb 14, 2023 | SC 13G/A | Major Ownership Report | |
| Feb 14, 2023 | 5 | Insider Trading | |
| Feb 14, 2023 | 5 | Insider Trading | |
| Feb 14, 2023 | SC 13G/A | Major Ownership Report | |
| Feb 14, 2023 | SC 13G/A | Major Ownership Report |
Latest Insider Trading transactions for DOCS
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-02-21 | EMERGENCE CAPITAL PARTNERS II LP | sold | - | - | -1,446,000 | - |
2023-02-21 | EMERGENCE CAPITAL PARTNERS II LP | acquired | - | - | 1,446,000 | - |
2023-02-21 | Spain Kevin | sold | - | - | -1,446,000 | - |
2023-02-21 | Spain Kevin | acquired | - | - | 1,446,000 | - |
2023-02-15 | Cabral Timothy S | acquired | - | - | 7,500 | - |
2023-02-15 | Cabral Timothy S | sold | -262,500 | 35.00 | -7,500 | - |
2023-02-15 | Jorgensen Paul W. | sold (taxes) | -44,680 | 33.17 | -1,347 | chief revenue officer |
2023-02-14 | Cabral Timothy S | acquired | - | - | 10,000 | - |
2023-02-14 | Cabral Timothy S | sold | -325,458 | 32.5458 | -10,000 | - |
2023-02-02 | Bryson Anna | sold | -1,000,000 | 40.00 | -25,000 | chief financial officer |
Jeffrey A. Tangney
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
DOCS Income Statement
2022-09-30CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
| Income Statement [Abstract] | ||||
| Revenue | $ 102,185 | $ 79,350 | $ 192,824 | $ 152,019 |
| Cost of revenue | 13,210 | 8,951 | 26,287 | 16,937 |
| Gross profit | 88,975 | 70,399 | 166,537 | 135,082 |
| Operating expenses: | ||||
| Research and development | 19,104 | 15,460 | 38,126 | 28,701 |
| Sales and marketing | 29,021 | 21,161 | 57,155 | 40,532 |
| General and administrative | 8,749 | 8,827 | 17,473 | 16,023 |
| Total operating expenses | 56,874 | 45,448 | 112,754 | 85,256 |
| Income from operations | 32,101 | 24,951 | 53,783 | 49,826 |
| Other income, net | 908 | 420 | 1,712 | 465 |
| Income before income taxes | 33,009 | 25,371 | 55,495 | 50,291 |
| Provision for (benefit from) income taxes | 6,710 | (10,717) | 6,813 | (12,119) |
| Net income | 26,299 | 36,088 | 48,682 | 62,410 |
| Undistributed earnings attributable to participating securities, basic | 0 | 0 | 0 | (18,326) |
| Undistributed earnings attributable to participating securities, diluted | 0 | 0 | 0 | (18,326) |
| Net income attributable to Class A and Class B common stockholders, basic | 26,299 | 36,088 | 48,682 | 44,084 |
| Net income attributable to Class A and Class B common stockholders, diluted | $ 26,299 | $ 36,088 | $ 48,682 | $ 44,084 |
| Net income per share attributable to Class A and Class B common stockholders: | ||||
| Basic (in dollars per share) | $ 0.14 | $ 0.19 | $ 0.25 | $ 0.32 |
| Diluted (in dollars per share) | $ 0.12 | $ 0.17 | $ 0.23 | $ 0.27 |
| Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders: | ||||
| Basic (in shares) | 193,137 | 186,171 | 193,042 | 137,154 |
| Diluted (in shares) | 213,949 | 216,672 | 214,452 | 166,066 |
DOCS Balance Sheet
2022-09-30CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2022 | Mar. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 73,674 | $ 112,809 |
| Marketable securities | 676,317 | 685,304 |
| Accounts receivable, net of allowance for doubtful accounts of $427 and $359 at September 30, 2022 and March 31, 2022, respectively | 79,236 | 81,073 |
| Prepaid expenses and other current assets | 15,691 | 19,439 |
| Deferred contract costs, current | 2,999 | 5,512 |
| Total current assets | 847,917 | 904,137 |
| Property and equipment, net | 11,647 | 8,488 |
| Deferred income tax assets | 50,583 | 48,558 |
| Operating lease right-of-use assets | 14,894 | 1,087 |
| Intangible assets, net | 34,232 | 7,909 |
| Goodwill | 67,940 | 18,915 |
| Other assets | 1,130 | 2,263 |
| Total assets | 1,028,343 | 991,357 |
| Current liabilities: | ||
| Accounts payable | 1,106 | 463 |
| Accrued expenses and other current liabilities | 26,408 | 25,270 |
| Deferred revenue, current | 89,616 | 84,907 |
| Operating lease liabilities, current | 1,013 | 642 |
| Total current liabilities | 118,143 | 111,282 |
| Deferred revenue, non-current | 166 | 78 |
| Operating lease liabilities, non-current | 14,625 | 447 |
| Contingent earn-out consideration liability, non-current | 15,422 | 0 |
| Other liabilities, non-current | 1,023 | 956 |
| Total liabilities | 149,379 | 112,763 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' Equity | ||
| Preferred stock, $0.001 par value; 100,000 shares authorized as of September 30, 2022 and March 31, 2022, respectively; zero shares issued and outstanding as of September 30, 2022 and March 31, 2022, respectively | 0 | 0 |
| Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of September 30, 2022 and March 31, 2022, respectively; 192,302 and 192,398 shares issued and outstanding as of September 30, 2022 and March 31, 2022, respectively | 192 | 192 |
| Additional paid-in capital | 730,582 | 702,589 |
| Accumulated other comprehensive loss | (21,559) | (15,294) |
| Retained earnings | 169,749 | 191,107 |
| Total stockholders’ equity | 878,964 | 878,594 |
| Total liabilities and stockholders’ equity | $ 1,028,343 | $ 991,357 |